Impact BioMedical Inc. (IBO)
IBO Stock Price Chart
Explore Impact BioMedical Inc. interactive price chart. Choose custom timeframes to analyze IBO price movements and trends.
IBO Company Profile
Discover essential business fundamentals and corporate details for Impact BioMedical Inc. (IBO) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
—
Employees
2.00
Website
https://www.impactbiomedinc.comCEO
Frank D. Heuszel
Description
Impact BioMedical Inc. engages in the discovery and development of products and treatment options in specialty biopharmaceuticals and consumer healthcare. It provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone. The company also develops functional fragrance formulation, a suite of functional fragrances containing specialized botanical ingredients with application as an antimicrobial, and as an additive in insect repellents, detergents, lotions, shampoo, fabrics, and other substances. In addition, it develops Equivir/Equivir G technology, a novel blend of polyphenols, which have demonstrated antiviral effects for use in as health supplements and medications. The company was incorporated in 2018 and is based in Houston, Texas.
IBO Financial Timeline
Browse a chronological timeline of Impact BioMedical Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 14 Aug 2025
EPS came in at -$1.18 , while revenue for the quarter reached $7.00K .
Earnings released on 14 May 2025
EPS came in at -$0.11 .
Earnings released on 28 Mar 2025
EPS came in at -$0.42 .
Earnings released on 12 Nov 2024
EPS came in at -$0.02 .
Earnings released on 13 Aug 2024
EPS came in at -$0.08 .
Earnings released on 10 May 2024
EPS came in at -$0.08 .
Earnings released on 20 Feb 2024
EPS came in at -$0.04 .
Earnings released on 13 Nov 2023
EPS came in at -$0.02 .
Earnings released on 5 Oct 2023
EPS came in at -$0.02 .
Earnings released on 30 Apr 2023
EPS came in at -$0.00 , while revenue for the quarter reached $428.33K .
Earnings released on 31 Jan 2023
EPS came in at -$0.00 , while revenue for the quarter reached $41.27K .
Earnings released on 31 Oct 2022
EPS came in at -$0.00 .
Earnings released on 31 Jul 2022
EPS came in at -$0.03 , while revenue for the quarter reached $131.20K .
Earnings released on 30 Apr 2022
EPS came in at -$0.01 , while revenue for the quarter reached $369.12K .
Earnings released on 31 Jan 2022
EPS came in at -$0.01 , while revenue for the quarter reached $433.16K .
Earnings released on 31 Oct 2021
EPS came in at -$0.01 , while revenue for the quarter reached $137.32K .
Earnings released on 30 Jun 2021
EPS came in at -$0.00 .
Earnings released on 31 Mar 2021
EPS came in at -$0.01 .
Earnings released on 31 Dec 2020
EPS came in at -$0.01 .
Earnings released on 30 Sept 2020
EPS came in at -$0.01 .
IBO Stock Performance
Access detailed IBO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.